• Mashup Score: 0

    Accelerating Cures and TreatmentsOver 350 million people in the world have a rare disease, but only about 10% of rare diseases have an FDA-approved treatment. Drug development can be extremely challenging for rare diseases because of the often small patient populations and a limited understanding of how these diseases can manifest and progress. If we can bring together the experience of patients,…

    Tweet Tweets with this article
    • To learn more about #RDCADAP, view resources, or read frequently asked questions please visit NORD’s website: https://t.co/38I9lwyCiy

  • Mashup Score: 2

    ‎Health & Fitness · 2021

    Tweet Tweets with this article
    • New episode of #NORDpod now available: https://t.co/iVTGwzQnEj NORD Chief Medical & Scientific Officer Edward Neilan discusses the #RareDisease Cures Accelerator-Data and Analytics Platform (#RDCADAP). Listen now! @CPathInstitute https://t.co/hNaLLe5PMK

  • Mashup Score: 3

    Tuesday, November 30,2021; 2:00pm ET Patient-Focused Drug Development (PFDD) is a process that provides patients and caregivers impacted by a rare disease the opportunity to share their experience with those directly involved in the drug development process. The Rare Disease Cures Accelerator, a Data Analysis Platform (RDCA-DAP®), a collaboration between the National Organization for Rare…

    Tweet Tweets with this article
    • New #webinar: "Patient-Focused Drug Development (PFDD): How RDCA-DAP Can Help” on November 30 at 2:00pm ET. Learn how #RDCADAP can strengthen #PFDD efforts to support life-saving & life-changing outcomes. #NORD @CPathInstitute @FDA @KrabbeConnect Register: https://t.co/mYWhnRE1UD https://t.co/p1B2QWxam4

  • Mashup Score: 2

    Tuesday, November 30,2021; 2:00pm ET Patient-Focused Drug Development (PFDD) is a process that provides patients and caregivers impacted by a rare disease the opportunity to share their experience with those directly involved in the drug development process. The Rare Disease Cures Accelerator, a Data Analysis Platform (RDCA-DAP®), a collaboration between the National Organization for Rare…

    Tweet Tweets with this article
    • New #webinar: "Patient-Focused Drug Development (PFDD): How RDCA-DAP Can Help” on November 30 at 2:00pm ET. Learn how #RDCADAP can strengthen #PFDD efforts to support life-saving & life-changing outcomes. #NORD @CPathInstitute @FDA @KrabbeConnect Register: https://t.co/mYWhnRE1UD https://t.co/h9JjdhEDou

  • Mashup Score: 5

    Tuesday, November 30,2021; 2:00pm ET Patient-Focused Drug Development (PFDD) is a process that provides patients and caregivers impacted by a rare disease the opportunity to share their experience with those directly involved in the drug development process. The Rare Disease Cures Accelerator, a Data Analysis Platform (RDCA-DAP®), a collaboration between the National Organization for Rare…

    Tweet Tweets with this article
    • New #webinar: "Patient-Focused Drug Development (PFDD): How RDCA-DAP Can Help” on November 30 at 2:00pm ET. Learn how #RDCADAP can strengthen #PFDD efforts to support life-saving & life-changing outcomes. #NORD @CPathInstitute @FDA @KrabbeConnect Register: https://t.co/mYWhnRE1UD https://t.co/Usc5hGyoh8

  • Mashup Score: 0

    Tuesday, November 30,2021; 2:00pm ET Patient-Focused Drug Development (PFDD) is a process that provides patients and caregivers impacted by a rare disease the opportunity to share their experience with those directly involved in the drug development process. The Rare Disease Cures Accelerator, a Data Analysis Platform (RDCA-DAP®), a collaboration between the National Organization for Rare…

    Tweet Tweets with this article
    • New #webinar: "Patient-Focused Drug Development (PFDD): How RDCA-DAP Can Help” on November 30 at 2:00pm ET. Learn how #RDCADAP can strengthen #PFDD efforts to support life-saving & life-changing outcomes. #NORD @CPathInstitute @FDA @KrabbeConnect Register: https://t.co/mYWhnRE1UD https://t.co/pe4zV5p9Nc